Perform world-class research—advance our understanding of cancer genomics
Illumina next-generation sequencing (NGS) and microarray technologies represent the gold standard in quality worldwide—and account for ~90% of the world’s sequencing data.* Innovative, intuitive, and completely integrated, our sample-to-data solutions empower your lab to keep ahead of the curve in the rapidly evolving genomics revolution. So you’ll be better able to perform the world-class research you strive for—with the goal of uncovering new insights into the biology of cancer that can lead to meaningful advances in personalized medicine.
Our comprehensive product offerings support multiple cancer research applications, including studies of DNA, RNA, epigenetics, and more. Our range of sequencers can be scaled to meet your needs—from powerful, yet personal, benchtop models to versatile, high-throughput systems. With intuitive data analysis and management capabilities and unsurpassed customer support, we can deliver the answers you seek—quickly, accurately, and cost-effectively.
Cancer Genomics Research
Explore genomics-based approaches to investigating cancer using NGS and microarrays.
- Cancer Sequencing Methods
- Cancer Immunotherapy Research
- Cancer Epigenetics
- Chromosomal Abnormalities
- Products and Services
- Resources
Cancer Sequencing Methods
NGS methods enable cancer researchers to perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.
Cancer Immunotherapy Research
Immuno-oncology is an emerging field that has taken great strides in the fight against cancer, bolstered by a refined understanding of how tumors evade the natural immune response. Research into the mechanisms tumors use to inhibit the immune response have led to promising therapeutic targets.
Cancer Epigenetics
Changes in gene activation or gene silencing can impact the rate of cancer progression. Studying the epigenetic changes that influence gene expression can provide insight into important tumorigenic pathways.
Chromosomal Abnormalities
Genomic instability and chromosomal abnormalities are common features of cancer. Understanding these structural aberrations can inform studies of cancer etiology.
Products and Services
Illumina offers various NGS and microarray products and services to support cancer genomics research.
Resources
Learn more about Illumina technology and how it is being used in cancer research. Access publications, videos, webinars, and other educational resources.
Cancer Genomics Research Stories
NGS Panels Demonstrate Value in Brain Tumor Studies
TruSight Tumor 170 accurately identifies diffuse glioma genetic markers, supporting use in tumor characterization for clinical research studies.
Read Interview
Deciphering the Role of Long Non-Coding RNA in Cancer
Researchers are using RNA-Seq to reveal how lncRNAs could be used to identify, measure, and treat cancer.
Read Interview
A New View of Cancer Pathways in Pediatric Leukemia
Researchers use targeted RNA sequencing to understand the role of fusion genes in pediatric leukemia.
Read InterviewBeginner's Guide to Next-Generation Sequencing
Considering bringing next-generation sequencing to your lab, but unsure where to start? These resources cover key topics in NGS and are designed to help you plan your first experiment.
Get Started
Learn More
Genomic Technologies for Cancer Research
Learn the numerous ways that genomic technologies can be applied to tumor biology.
Cancer Research Review
An overview of recent cancer genomics research publications featuring Illumina technology.
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Insights into Leukemia and Lymphoma
Munich Leukemia Laboratory is using NGS to gain a better understanding of leukemia and lymphoma subtypes and discover new therapeutic pathways.
Exploring the Forgotten Genome of Cancer Research
A Garvan Institute sarcoma study identifies rare cancer-associated variants in the germline.
Methods Guide
All the information you need, from BeadChips to library preparation to sequencer selection and analysis. Select the best tools for your lab.
Sequencing Analysis of Tissue Samples: Fresh Frozen vs. FFPE
A researcher from Massachusetts General Hospital compares sequencing results from FFPE and fresh-frozen tumor samples.
References
*Data on file based on a 2013 study.